FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort

BACKGROUND: The role of second-line therapy in gastric cancer patients mostly stemmed from clinical trials with monochemotherapy carried out in Asian countries. Nevertheless, these results cannot be broadly generalized as molecular studies suggested the existence of different sets of deregulated gen...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Main Authors:	Maugeri-Saccà, Marcello, Pizzuti, Laura, Sergi, Domenico, Barba, Maddalena, Belli, Franca, Fattoruso, Silvia Ileana, Giannarelli, Diana, Amodio, Antonella, Boggia, Sara, Vici, Patrizia, Di Lauro, Luigi
Format:	Artigo
Sprog:	Inglês
Udgivet:	BioMed Central 2013
Fag:	Research
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3850248/ https://ncbi.nlm.nih.gov/pubmed/24330513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-32-67
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort

Lignende værker